Éric Oksenhendler
- Oncology top 0.2%
- Viral-associated cancers and disorders 77
- Virology top 1%
- Immunology top 0.5%
- Immunodeficiency and Autoimmune Disorders 26
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 46
- Infectious Diseases top 0.5%
- Parvovirus B19 Infection Studies 24
-
- Platelet Disorders and Treatments 26
- Blood groups and transfusion 24
-
- Chronic Lymphocytic Leukemia Research 21
-
- Histiocytic Disorders and Treatments 20
- Co-authors
- Martine RaphaëlP. CacoubJean SoulierDominique Cazals‐HatemJP ClauvelLionel GalicierJean‐Pierre ClauvelL Grollet
- Cited by
- OncologyVirologyImmunology
- Journals
- Blood (29 papers)British Journal of Haematology (11 papers)American Journal of Hematology (9 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Éric Oksenhendler
164 papers receiving 10.1k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 5.2k
- Virology 763
- Immunology 3.4k
- Pathology and Forensic Medicine 2.5k
- Infectious Diseases 2.3k
Countries citing papers authored by Éric Oksenhendler
This map shows the geographic impact of Éric Oksenhendler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Oksenhendler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Oksenhendler more than expected).
Fields of papers citing papers by Éric Oksenhendler
This network shows the impact of papers produced by Éric Oksenhendler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Oksenhendler. The network helps show where Éric Oksenhendler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Éric Oksenhendler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 13 | |
| 2 | 2023 | 12 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 1 | |
| 7 | Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committeebreakdown → | 2020 | 726 |
| 8 | 2018 | 11 | |
| 9 | 2016 | 3 | |
| 10 | 2015 | 50 | |
| 11 | 2011 | 10 | |
| 12 | 2008 | 30 | |
| 13 | 2003 | 61 | |
| 14 | 2003 | 8 | |
| 15 | KSHV infects monotypic (IgM lambda) but polyclonal naive B- cells in Castleman's disease and associated lymphoproliferative disorders | 2001 | 1 |
| 16 | 2001 | 12 | |
| 17 | 1999 | 81 | |
| 18 | Herpèsvirus humain 8 (HHV8) et pathologies lymphoïdes | 1998 | 1 |
| 19 | 1991 | 24 | |
| 20 | 1987 | 67 |
About Éric Oksenhendler
Éric Oksenhendler is a scholar working on Virology, Hematology, Pathology and Forensic Medicine, Oncology and Genetics, having authored 172 papers that have together received 10.3k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (77 papers), Lymphoma Diagnosis and Treatment (46 papers), Platelet Disorders and Treatments (26 papers), Immunodeficiency and Autoimmune Disorders (26 papers), Parvovirus B19 Infection Studies (24 papers), Blood groups and transfusion (24 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Histiocytic Disorders and Treatments (20 papers). The work is most often cited by research in Oncology (5.2k citations), Virology (763 citations), Immunology (3.4k citations), Pathology and Forensic Medicine (2.5k citations) and Infectious Diseases (2.3k citations). Éric Oksenhendler has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Martine Raphaël, P. Cacoub, Jean Soulier, Dominique Cazals‐Hatem, JP Clauvel, Lionel Galicier, Jean‐Pierre Clauvel, L Grollet, L Degos and P Babinet. Their work appears in journals such as Blood, British Journal of Haematology, American Journal of Hematology, AIDS and Journal of Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.